MONDAY, Feb. 24, 2025 — People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says.
Patients on semaglutide (Ozempic, Wegovy) had a…
You may also like
Boston Scientific Recalls Accolade Pacemaker Devices
Listeria Outbreak From Frozen Shakes Kills 12, Sickens...
Most Americans Don’t Know These Heart Disease Risks...
Study Finds No Spike in Cardiac Arrest in Athletes...
Breast Cancer A Killer In Poor Countries, Report Says
More ER Docs Prescribing Meds To Fight Opioid Addiction
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.